Research Funding Opportunities

NIH Funding Opportunities and Notices

 

General Notices

Review of the Accuracy of Grants Information for Fiscal Year 2021
(NOT-OD-21-186)
National Institutes of Health

Notice of Technical Assistance Webinar for Companion Awards for the Clinical and Translational Science Awards (UM1) Career Development and Training and Specialized Innovation Program Opportunities
(NOT-TR-21-035)
National Center for Advancing Translational Sciences

 

Notice of Changes to Funding Opportunities

 

Notice of Correction to RFA-CA-21-055, "Translational and Basic Science Research in Early Lesions: Coordinating and Data Management Center (U24 Clinical Trial Not Allowed)"
(NOT-CA-21-122)
National Cancer Institute

Notice of Extension of Application Due Date for RFA-DK-21-019, National Program for the Career Development Of Physician Scientists in Diabetes Research (Diabetes - Docs) (K12 Clinical Trial Optional)
(NOT-DK-21-030)
National Institute of Diabetes and Digestive and Kidney Diseases

Notice of NINR Participation in PA-21-049, Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions with NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30)
(NOT-NR-21-008)
National Institute of Nursing Research

Notice of Change to NOT-NR-21-001: "Notice of Special Interest (NOSI): NINR Priority Areas for Training and Career Development Awards"
(NOT-NR-21-009)
National Institute of Nursing Research

Notice of Early Expiration of PAR-20-316 "NIH Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54 - Clinical Trial Optional)"
(NOT-NS-22-029)
National Institute of Neurological Disorders and Stroke
National Eye Institute
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute on Drug Abuse
National Institute of Environmental Health Sciences

Notice of NEI, NIA, NIAAA, NIAMS, NIDA and NIDDK's Participation in RFA-NS-22-016 "HEAL Initiative: Interdisciplinary Teams to Elucidate the Mechanisms of Device-Based Pain Relief (RM1 Clinical Trial Optional)"
(NOT-NS-22-031)
National Institute of Neurological Disorders and Stroke
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute on Drug Abuse
National Institute of Diabetes and Digestive and Kidney Diseases

Notice of Intent to Publish a Funding Opportunity Announcement for SPARC VNS Endpoints from Standardized Parameters (VESPA) (U54 Clinical Trial Required)
(NOT-RM-22-001)
Office of Strategic Coordination (Common Fund)

NOSI: Notice of Special Interest: Resilience and Vulnerability following Acute Heart, Lung, Blood, and Sleep Insults in People with HIV (R01, Clinical Trial Not Allowed)
(NOT-HL-22-002)
National Heart, Lung, and Blood Institute

Notice of Special Interest: Biomarker Discover and Validation in Functional Neurological Disorders
(NOT-NS-22-010)
National Institute of Neurological Disorders and Stroke

Interventions for Stigma Reduction to Improve HIV/AIDS Prevention, Treatment and Care in Low- and Middle- Income Countries (R01 - Clinical Trial Optional)
(PAR-21-344)
John E. Fogarty International Center
National Cancer Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute of Mental Health
Application Receipt Date(s): December 20, 2022

The role of Epstein Barr virus (EBV) infection in Non-Hodgkin Lymphoma (NHL) and Hodgkin disease (HD) development with or without an underlying HIV infection (U01 Clinical Trial Optional)
(PAR-21-348)
National Cancer Institute
Application Receipt Date(s): December 15, 2023

NIA Career Transition Award (K22 Independent Clinical Trial Not Allowed)
(PAR-21-351)
National Institute on Aging
Application Receipt Date(s): February 12, 2022 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

NINDS Institutional AD/ADRD Research Training Program (T32 Clinical Trial Not Allowed)
(PAR-22-021)
National Institute of Neurological Disorders and Stroke
National Institute on Aging
Application Receipt Date(s): Multiple dates, see announcement.

Role of Astrocytes in Degeneration of the Neurovascular Unit in AD/ADRDs (R01 Clinical Trial Not Allowed)
(PAR-22-037)
National Institute of Neurological Disorders and Stroke
National Institute on Aging
Application Receipt Date(s): February 04, 2022

Systems Biology for Infectious Diseases (U19 Clinical Trial Not Allowed)
(RFA-AI-21-065)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): January 14, 2022 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

 

Postdoctoral Research Fellowships in Biology (PRFB)

Available Formats:

HTML: https://www.nsf.gov/pubs/2021/nsf21614/nsf21614.htm?WT.mc_id=USNSF_25&WT.mc_ev=click

PDF: https://www.nsf.gov/pubs/2021/nsf21614/nsf21614.pdf?WT.mc_id=USNSF_25&WT.mc_ev=click